The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Why Rheumatologists Should Join the AMA

Why Rheumatologists Should Join the AMA

October 14, 2015 • By Gary Bryant, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Other new policies direct the AMA to work with the ABMS toward the following:

You Might Also Like
  • ACR Seeks Members’ Help to Boost AMA Representation
  • Maintain Rheumatology’s Seat at the AMA Table
  • Pointers for Rheumatologists Considering AMA Membership
Explore This Issue
October 2015
Also By This Author
  • AMA House of Delegates Meeting: Decisions Affecting You
      • Any assessment should be used to guide physicians’ self-directed continuing medical education study.
      • Specific content-based feedback after any assessment should be provided to physicians in a timely manner.
      • Multiple options should be available for how an assessment could be structured to accommodate different learning styles.
      • Physicians need to know what their specific MOC requirements are and the timing around when they must complete those requirements. The policy directs the AMA to ask the ABMS and its member boards to develop a system to alert physicians to the due dates of the multi-stage requirements of MOC.
      • Part III of the MOC exam, known as the high-stakes exam, should be streamlined and improved, and alternative formats explored.

We also co-sponsored Resolution 235 with the American Association of Clinical Endocrinologists, AAAAI and Endocrine Society regarding the newly launched Interstate Medical Licensure Compact commission to clarify that the intent of the compact’s model legislation requiring that a physician “hold” specialty certification refers only to initial certification and not MOC. This was passed by the HOD.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

We co-sponsored Resolution 505 along with the dermatology caucus members regarding the difficulties we often face obtaining coverage for our patients for off-label use of medications. The HOD amended current policies and resolved to advocate that the FDA work to establish a process whereby official drug labeling can be updated in a more expeditious fashion when new evidence becomes available affecting the clinical use of prescription medications and that evidence-based standards or peer-reviewed medical literature can add to legacy information contained in official drug labeling statements to guide drug administration and usage.

In another effort with the dermatology caucus, we sponsored Resolution 702 regarding access to in-office administered drugs. This strengthens AMA policy that we had previously brought forward regarding this issue. Rheumatologists leverage our advocacy efforts and dollars by using the significant resources the AMA brings to bear.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

We have learned that AMA membership among ACR members has declined since 2012, and because our membership is now measured yearly, we lost our second delegate.

We can Advance Rheumatology! more forcefully and serve you and our patients better by having a larger voice at the AMA. We’re asking that rheumatologists who are not current members of the AMA join now for 2015 so rheumatology can keep our seat and remain involved in steering the direction of the AMA. Call the AMA at 800-262-3211. You can also contact ACR staff at [email protected] for assistance in becoming an AMA member or renewing your membership. If you are already an AMA member, make sure you have designated the ACR as your representative society.

Pages: 1 2 3 4 | Single Page

Filed Under: Legislation & Advocacy, Professional Topics Tagged With: AC&R, Advocacy, AMA, American College of Rheumatology, American Medical Association, Professional Matters, rheumatologists, rheumatologyIssue: October 2015

You Might Also Like:
  • ACR Seeks Members’ Help to Boost AMA Representation
  • Maintain Rheumatology’s Seat at the AMA Table
  • Pointers for Rheumatologists Considering AMA Membership
  • AMA House of Delegates Meeting: Decisions Affecting You

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)